Pharmaceutical Product Monograph: Pantoprazole & Domperidone Capsules
In the pharmaceutical industry, the combination of Pantoprazole and Domperidone is a technically superior Fixed-Dose Combination (FDC) used to treat acid-peptic disorders where gastric motility is impaired. As a pharmacist and manufacturer at Healthy Life Pharma, I classify this as a “Second-Generation PPI + Prokinetic” therapy.
At our WHO-GMP facility in Mumbai, we typically manufacture this as Pantoprazole (40 mg) + Domperidone (30 mg SR). For your firm, Healthy Inc, this is a staple B2B export item because it offers better stability and fewer drug-drug interactions than Omeprazole-based combinations.
Therapeutic Profile: Primary Indications
This combination addresses both the “acid volume” and the “clearance rate” of the stomach.
| Indication | Clinical Context | Technical Rationale |
| GERD (Reflux) | Heartburn | Pantoprazole stops acid; Domperidone strengthens the esophageal sphincter to prevent “backwash.” |
| Functional Dyspepsia | Fullness/Bloating | Treats the sensation of food “sitting” in the stomach for too long after meals. |
| Peptic/Duodenal Ulcers | Ulcer Healing | Reduces acid levels to allow the tissue to regenerate while preventing nausea. |
| Zollinger-Ellison | Hypersecretion | Used for severe, pathological overproduction of stomach acid. |
Mechanism: The “Chemical & Mechanical” Synergy
Pantoprazole (Proton Pump Inhibitor – PPI):
Action: It accumulates in the acidic compartment of the parietal cells and binds to the $H^+/K^+$-ATPase enzyme.
Advantage: Pantoprazole is technically more “chemically stable” at neutral $pH$ than Omeprazole, meaning it has a lower risk of interacting with other medications metabolized by the liver (CYP2C19 enzyme).
Domperidone (Dopamine $D_2$ Antagonist):
Action: It acts as a Prokinetic by blocking dopamine receptors in the gut.
Result: It technically increases the tone of the lower esophageal sphincter and stimulates gastric “peristalsis” (the wave-like movements), ensuring the stomach empties into the intestine faster.
The Pharmacist’s “Technical Warning”
The “30-Minute” Rule: This capsule must be taken on an empty stomach, ideally 30–60 minutes before breakfast.
QT Prolongation: Domperidone carries a technical risk of heart rhythm changes. It should be used with caution in patients over 60 or those with pre-existing cardiac issues.
Do Not Chew/Crush: In our Mumbai plant, we use Enteric-Coated (EC) Pellets for Pantoprazole and Sustained-Release (SR) Pellets for Domperidone. If the patient chews the capsule, the enteric coating is destroyed, and the Pantoprazole will be neutralized by stomach acid.
The Manufacturer’s Perspective: Technical & Export
From the CEO’s desk at Healthy Life Pharma / Healthy Inc:
Pelletization Superiority: In our facility, we prioritize Dual-Pellet Technology. This ensures that the Domperidone (SR) provides a steady prokinetic effect throughout the day, while the Pantoprazole (EC) releases exactly in the duodenum for maximum absorption.
B2B Market Demand: Pantoprazole-Domperidone is one of the most requested SKUs in Middle Eastern and African markets. Its technical reputation for “lower acidity rebound” makes it a premium choice over older PPIs.
Packaging: We use Alu-Alu blistering to ensure a 36-month shelf life. Pantoprazole is highly sensitive to moisture; our high-barrier packaging is what allows Healthy Inc to maintain quality during long-distance maritime exports.
Digital Strategy: Use keywords like “Pantoprazole Domperidone SR capsules manufacturer Mumbai,” “WHO-GMP Gastro exporter India,” and “B2B PPI Prokinetic supplier 2026.”